跳至主要内容
临床试验/NCT02215694
NCT02215694已完成3 期

Supplementation of Dual Probiotic Strains, Lactobacillus Curvatus HY7601 and Lactobacillus Plantarum KY1032, Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels in Nondiabetic and Hypertriglyceridemic Subjects

Yonsei University2 个研究点 分布在 1 个国家目标入组 128 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
128
试验地点
2
主要终点
ApoA5-1131 genotype

研究概览

简要总结

The purpose of this study is to evaluate the effect of dual probiotic strains containing Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on triglyceride and apolipoprotein A-V.

详细描述

A randomized, double-blind, placebo-controlled study was conducted on 128 nondiabetic and hypertriglyceridemic (Plasma Triglyceride, 150-500 mg/dL) subjects. Over a 12 week test period, the probiotic group consumed 2g of powder daily containing dual probiotic strains, while the placebo group consumed the same without probiotics.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Double (Participant, Investigator)

入排标准

年龄范围
24 Years 至 68 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • nondiabetic (plasma fasting glucose, <126mg/dL; 2-hour plasma glucose, <200mg/dL)
  • borderline to moderate hypertriglyceridemia (plasma triglyceride, 150-500 mg/dL)

排除标准

  • lipid-lowering medications use
  • any medications or supplement use
  • any probiotics products use for the past 1 months
  • dyslipidemia
  • diabetes mellitus
  • hypertension
  • liver disease
  • renal disease
  • cardiovascular disease
  • cerebrovascular disease
  • pancreatitis
  • medication or alcohol abuse
  • pregnant or breast feeding

结局指标

主要结局

ApoA5-1131 genotype

时间窗: at baseline

ApoA5-1131 T\>C

次要结局

  • Fasting glucose at baseline and 12-week follow-up(12-week follow-up)
  • Apolipoprotein A-V at baseline and 12-week follow-up(12-week follow-up)
  • C-peptide at baseline and 12-week follow-up(12-week follow-up)
  • Free fatty acid at baseline and 12-week follow-up(12-week follow-up)
  • Insulin at baseline and 12-week follow-up(12-week follow-up)
  • Triglyceride at baseline and 12-week follow-up(12-week follow-up)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验